Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Senores Pharma to acquire two products of USFDA approved ANDAs from Teva Pharma USA

AstraZeneca concludes acquisition of Neogene Therapeutics

Ruchika Sharma17 Jan 2023 1:15 PM IST

UK: AstraZeneca has completed the acquisition of Neogene Therapeutics Inc.. Neogene will operate as a wholly-owned subsidiary of AstraZeneca, with...

Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark

Roche gets European Commission nod for Xofluza to treat influenza in children aged one year and above

Ruchika Sharma17 Jan 2023 12:15 PM IST

Influenza is a serious infectious disease and represents a significant threat to public health.

Serum Institute Gets NPPA Nod to Discontinue Two Pack Sizes of Tetanus Toxoid Vaccine

COVID vaccine: DCGI approves market authorisation for Serum Institute Covovax as heterologous booster dose

Ruchika Sharma17 Jan 2023 11:14 AM IST

Covovax is manufactured through technology transfer from Novavax.

USFDA approves label update for Rybelsus allowing use as first-line option for adults with type 2 diabetes: Novo Nordisk

Ruchika Sharma16 Jan 2023 4:15 PM IST

Plainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has approved a label update for Rybelsus (semaglutide) tablets...

Lupin bags USFDA nod for Dolutegravir, Rilpivirine tablets to treat HIV infection

Ruchika Sharma16 Jan 2023 3:20 PM IST

Mumbai: Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration...

Solara Active Pharma Sciences Mangalore facility successfully completes USFDA inspection

USFDA issues 3 observations for Granules India Gagillapur facility

Ruchika Sharma16 Jan 2023 2:30 PM IST

Hyderabad: Granules India has recently announced that US Food and Drug Administration (USFDA) has concluded Pre-Approval Inspection (PAI) with three...

Lupin secures SBTi validation for emission reduction targets

Lupin gets 2 USFDA observations for Somerset facility

Ruchika Sharma16 Jan 2023 1:15 PM IST

Mumbai: Lupin has announced that the company has received two observations from the US Food and Drug Administration (USFDA) at the closure of...

Zydus Lifesciences arm bags USFDA okay for Major Depressive Disorder drug Levomilnacipran Extended-Release

Ruchika Sharma16 Jan 2023 12:15 PM IST

Ahmedabad: Zydus Lifesciences Limited’s (formerly known as Cadila Healthcare Limited) subsidiary Zydus Pharmaceuticals (USA) Inc. (Zydus) has...

NPPA Panel Rejects Dr Reddys Omez ODT Plea For Seperate Price, Finds No Therapeutic Edge

Dr Reddy's Labs acquires trademark rights of breast cancer drug from Pfizer

Ruchika Sharma16 Jan 2023 11:00 AM IST

The in-house product will be retailed in the Indian market at a reduction of 85% from the current MRP to increase affordability and access to...

Cancer MedTech Gets Clarity: CDSCO Releases Final Oncology Device Risk Classification List

Budget FY24: AiMeD recommends increasing custom duty on import of Chinese medical devices

Ruchika Sharma15 Jan 2023 1:45 PM IST

Instead of 18 percent GST applicable on some medical Devices that are not luxury goods, the industry body recommended that the GST needs to be a flat...

Novartis opens new radioligand therapy manufacturing facility in California

EMA seeks to issue guidance on liver damage from Novartis gene therapy Zolgensma

Ruchika Sharma15 Jan 2023 12:15 PM IST

The drug won conditional EU approval during early 2020 and it costs more than $2 million per patient

Over 15000 Jan Aushadhi Kendras opened till last month under PMBJP scheme across country: Minister

Centre approves Pharmaceuticals and Medical Devices Bureau of India proposal to invite online applications for opening Janaushadhi Kendra in 651 districts

Ruchika Sharma15 Jan 2023 10:00 AM IST

PMBJP was launched by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers with the objective of making quality generic medicines...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok